[Alternatives to hormonal treatment for the prevention of postmenopausal osteoporosis: the bisphosphonates].
Trémollières
F
F
Unité Ménopause et Maladies Osseuses Métaboliques, Service d'Endocrinologie, CHU Rangueil, 31403 Toulouse, France.
D000375:Aging; D019386:Alendronate / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D012968:Etidronic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D000068296:Risedronic Acid
D004164:Diphosphonates; D000068296:Risedronic Acid; D012968:Etidronic Acid; D019386:Alendronate
Les alternatives du traitement hormonal dans la prévention de l'ostéoporose post-ménopausique: les bisphosphonates.